https://orcid.org/0000-0002-8899-6804
References
- Nanovsky S, Arynov Z, Alzhanova A. The impact of non-pharmaceutical interventions on the growth rate of new COVID-19 cases: evidence from Kazakhstan and Kyrgyzstan. Research Square, PPR343829 [Preprint]; 2021 [cited 2024 Jan 29]. Available from: https://www.researchsquare.com/article/rs-535065/v1
- Loukia P. 37 million people a day are being infected with COVID-19 in China. [Internet]; 2022 Dec [cited 2023 Jan 13]. Available from: https://interestingengineering.com/health/37-million-people-a-day-are-being-infected-with-covid-19-in-china
- GT staff reporters. Severe cases account for 3-4% of total hospitalized patients in Beijing, lower than early, 2020 outbreak level: experts. [Internet]; 2022 [cited 2023 Jan 13]. Available from: https://www.globaltimes.cn/page/202212/1282963.shtml
- Bai Y, Peng Z, Wei F, Jin Z, Wang J, Xu X, et al. Study of the COVID-19 epidemic in mainland China between November 2022 and January 2023, with prediction of its tendency. J Biosaf Biosecur. 2023 Mar;5:39–5. doi: 10.1016/j.jobb.2023.03.001 Epub 2023 Mar 22. PMID: 36992708; PMCID: PMC10030260.
- CGTN. China to face three waves of COVID-19 infections this winter: expert [internet]. Beijing (China): CGTN; 2022 [cited 2023 Jan 14]. Available from: https://news.cgtn.com/news/2022-12-18/China-to-face-three-waves-of-COVID-19-infections-this-winter-Expert-1fRkj43lNmw/index.html
- Ma T, Chen C, Wang J, Wang H, Zhao Y, Zhu Y, et al. Parametric analysis of the transmission dynamics during indigenous aggregated outbreaks caused by five SARS-CoV-2 strains in Nanjing, China. Front Public Health. 2024 Mar 8;12:1358577. doi: 10.3389/fpubh.2024.1358577. PMID: 38525336; PMCID: PMC10959284.
- Wang G, Yao Y, Wang Y, Gong J, Meng Q, Wang H, et al. COVID-19 non-vaccination among older adults in China: a nationwide survey based on the China Health and Retirement Longitudinal Study (CHARLS). Res Sq [Preprint]. 2022 Dec 19;rs.3.rs–2380496. doi: 10.21203/rs.3.rs-2380496/v1 Update in: Nat Med. 2023 Jan 31; PMID: 36597533; PMCID: PMC9810236.
- Wu J, Ma M, Miao Y, Ye B, Li Q, Tarimo CS, et al. COVID-19 vaccination acceptance among Chinese population and its implications for the pandemic: a national cross-sectional study. Front Public Health. 2022 Feb 8;10–796467. doi: 10.3389/fpubh.2022.796467 PMID: 35211440; PMCID: PMC8860971.
- Lampl BMJ, Lang M, Jochem C, Leitzmann MF, Salzberger B. COVID or not COVID: attributing and reporting cause of death in a community cohort. Public Health. 2022 Apr;205:157–163. doi: 10.1016/j.puhe.2022.02.008 Epub 2022 Mar 11. PMID: 35287022; PMCID: PMC8916663.
- Du Z, Wang Y, Bai Y, Wang L, Cowling BJ, Meyers LA. Estimate of COVID-19 deaths, China, December 2022–February 2023. Emerg Infect Dis. 2023 Oct;29:2121–2124. doi: 10.3201/eid2910.230585 Epub 2023, Aug. 28. PMID: 37640373; PMCID: PMC10521589.
- Chen B, Xue Y, Jing H, Wang X, Zhu P, Hao W, et al. Effectiveness of Chinese medicine formula huashibaidu granule on mild COVID-19 patients: a prospective, non-randomized, controlled trial. Integr Med Res. 2023 Jun;12:100950. doi: 10.1016/j.imr.2023.100950 Epub 2023 Apr 21. PMID: 37192979; PMCID: PMC10121152.
- Kumar RP, Santra PK, Mahapatra GS. Global stability and analyzing the sensitivity of the parameters of a multiple-susceptible population model in SARS-CoV-2 emphasizing vaccination drives. Math Comput Simul. 2023;203:741–766. doi: 10.1016/j.matcom.2022.07.012